Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.269
+0.019 (1.52%)
Dec 27, 2024, 10:48 AM EST - Market open
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $212.94 million as of December 27, 2024. Its market cap has increased by 11.54% in one year.
Market Cap
212.94M
Enterprise Value
150.04M
1-Year Change
11.54%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $212.94M, a decrease of -90.70%. That is a compound annual growth rate of -49.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 206.40M | -11.82% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SOPHiA GENETICS | 209.95M |
| Inhibrx Biosciences | 209.76M |
| Profound Medical | 209.33M |
| Ocugen | 209.23M |
| Utah Medical Products | 208.35M |
| Compass Therapeutics | 206.38M |
| MacroGenics | 204.61M |
| Inventiva | 202.65M |